We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Microchip Test Identifies Antibiotic-Resistant Bacteria

By Biotechdaily staff writers
Posted on 11 Sep 2007
A microchip test quickly and inexpensively identifies dangerous drug resistant bacteria in clinical samples.

The miniaturized microarray chips were developed by studying and identifying the dangerous genes from samples of gut bacteria including the diarrhea-causing Escherichia coli and Salmonella, which causes food poisoning. More...


In a test of the new chip screening technique, the most common antibiotic resistance gene was identified in 90% of E. coli and 56% of Salmonella bacteria from a random group of animal and human clinical samples. The tests also identified unique and previously unknown combinations of virulence genes, whose significance has not yet been determined.

Physicians and veterinarians will be able to test clinical samples from their patients for the presence of the genes for antibiotic resistance in bacteria, and receive the results within 24 hours instead of having to wait for as much as a week.

"We have developed a test chip which can accurately identify 56 virulence genes in E. coli bacteria and 54 antimicrobial resistance genes covering all the known families of Gram-negative bacteria,” said Dr. Muna Anjum from the UK Veterinary Laboratories Agency in Addlestone (UK) where the new test was developed. "Our chips have already been used very successfully in a survey of microbial resistance in human clinical isolates, foods, farm animals, and also in wild animals, where we were looking at them as possible reservoirs of infection which can transmit disease back into farm animals.”

The microchip technology will allow scientists to search for and identify important genes from other pathogens and bacteria, such as genes that may be commercially important in industrial processes such as food processing, pharmaceutical development and waste handling.

The scientists presented their new test at the Society for General Microbiology's 161st meeting, which took place at the University of Edinburgh (Edinburgh, UK), on September 3-6, 2007.


Related Links:
University of Edinburgh
UK Veterinary Laboratories Agency in Addlestone

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.